Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

PepMix™ Peptide Pools for Gene Therapy & Immunogenicity Test

PepMix™ Peptide Pools for Gene Therapy and Immunogenicity Testing! Published on 15/11/2024 Imagine treating diseases by tweaking a person’s genetic code! This is gene therapy in a nutshell. By swapping out faulty genes, silencing malfunctioning genes, or even

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

PepMix™ Peptide Pools for Gene Therapy and Immunogenicity Testing!

Published on 15/11/2024

Imagine treating diseases by tweaking a person’s genetic code! This is gene therapy in a nutshell. By swapping out faulty genes, silencing malfunctioning genes, or even adding new genes, scientists can tackle complex conditions like hemophilia, cystic fibrosis, and certain immune deficiencies.

Delivering Genes

Naked DNA: Simple, but limited in effectiveness. CRISPR-Cas9 tools breathe new life into this method, although non-human proteins like Cas9 can trigger immune reactions. To monitor and manage these, we have developed a Cas9 PepMix™ peptide pool for effective immune monitoring.

Vector-Based Transfer: Viruses such as adenovirus (AdV) and adeno-associated virus (AAV) act as delivery vehicles for gene therapy. We offer a wide variety of different AAV and AdV PepMix™ peptide pools for immune testing against viral proteins like hexon, penton, and capsid proteins.

Peptide Pools are Key Players for Immune Monitoring & Immunogenicity Testing

Immunogenicity testing keeps gene therapies safe by ensuring that treatments do not cause unwanted immune responses. Our PepMix™ Peptide Pools are essential tools for immune monitoring and immunogenicity testing. Use them to

Track immune responses during gene therapy to measure efficacy. Peptide pools enable detailed assessment of T-cell response with common techniques like ELISpot and ICS.

Test for immune responses to viral vectors or proteins like Cas9, to ensure that therapies are as safe as they are effective.

Also evaluate a potential immune response towards the expressed therapeutic protein. JPT can produce your target protein in a peptide pool format adapted to ICS or ELIspot immune monitoring.

Measure immunogenicity against vector's proteins (Cas9, AAV capsid...) to ensure safety of your vector. A wide range of proteins are available on our catalog and others can be customized.

See All Peptides for Gene Therapy

Browse our peptide catalog to find all peptides for gene therapy development, such as Antigen Peptides, Peptide Pools or Peptide Microarrays.

Did not find what you were looking for? Need a different specification? Send us a quote request!

The Future is Bright for Gene Therapy!

Gene therapy is redefining the boundaries of modern medicine, and peptide tools are an essential part of the journey. Whether for immune monitoring, immunogenicity testing, or vaccine development, peptides keep gene therapy moving forward safely and effectively.

Want to learn more?

Our team is ready! Please reach out to our team of experts.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Epitope Mapping Peptide Sets (EMPS) in Research

PepMix™ Peptide Pools are invaluable for studying immune responses, particularly in vaccine development and infectious disease research. JPT’s EMPS peptide pools are specifically designed to enhance the understanding of T cell reactivity and antigen-specific immune responses. Below, you will find a key study referencing JPT’s PepMix™ Peptide Pools in researches.

Source: jpt.com ↗

JPT's Tumor Associated Antigens for Research

PepMix™ Peptide Pools are instrumental in cancer immunotherapy, particularly for exploring tumor-associated antigens and improving T cell responses. JPT’s PepMix™ Peptide Pools support the development of novel cancer vaccines and therapeutic strategies targeting tumor-specific markers. Below, you will find key studies referencing JPT’s PepMix™ Peptide Pools in research.

Source: jpt.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

Benefits of Custom SpikeMix™ - Reference Peptide Pools

Unmatched turnaround times and prices Aliquotation service available Quantification of multiple proteins from a single sample Multiplexed analysis of disease status and therapeutic success

Source: jpt.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →